Henrik Vestergaard

Henrik Vestergaard

Associate Professor


  1. Published

    Rosiglitazone treatment of patients with extreme insulin resistance and diabetes mellitus due to insulin receptor mutations has no effects on glucose and lipid metabolism. / Vestergaard, H; Lund, S; Pedersen, O; Vestergaard, Henrik.

    In: Journal of Internal Medicine, Vol. 250, No. 5, 11.2001, p. 406-14.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Increments in insulin sensitivity during intensive treatment are closely correlated with decrements in glucocorticoid receptor mRNA in skeletal muscle from patients with Type II diabetes. / Vestergaard, H; Bratholm, P; Christensen, N J.

    In: Clinical Science, Vol. 101, No. 5, 11.2001, p. 533-40.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Serum leptin levels in pregnant women with type 1 diabetes mellitus. / Lauszus, Finn; Schmitz, Ole; Vestergaard, H; Klebe, J G; Pedersen, O; Vestergaard, Henrik.

    In: Acta Obstetricia et Gynecologica Scandinavica, Vol. 80, No. 7, 07.2001, p. 596-601.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Studies of variability in the PTEN gene among Danish caucasian patients with Type II diabetes mellitus. / Hansen, L; Jensen, J N; Ekstrøm, C T; Vestergaard, H; Hansen, T; Pedersen, O; Vestergaard, Henrik.

    In: Diabetologia, Vol. 44, No. 2, 02.2001, p. 237-240.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 32017192